By using IGV, public mRNA-expression data from Nextbio, and IPA, we concluded that ABCA1 was a major hyper-methylated promoter or downregulated gene discriminating PAH and control (Figures 5, 6, Table 5). This evidence concerns the gene ABCA1 and pulmonary arterial hypertension.